News
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Evoke Pharma shares surged after the company received a notice of allowance for a U.S. patent application for Gimoti extending Orange Book listings to 2036.
AI is a useful drafting tool. But it is important to know of the potential risks at the outset and to ensure that the proper ...
The STREAM IP platform is designed to simplify international patent filing through insights, integration, and intelligent ...
1d
InvestorsHub on MSNEvoke Pharma Shares Jump 50% Following Patent Approval for GIMOTIEvoke Pharma Inc (NASDAQ:EVOK) saw its stock soar 50% after the specialty pharma company received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application covering ...
Recent cases show some successes by trademark plaintiffs stating claims for trade dress infringement despite their product being disclosed in a utility patent, at least at the pleadings stage.
With a patent portfolio including over 40 patents, Jungo's intellectual property covers core innovations in in-cabin driver behavior analysis, video telematics, driver monitoring systems (DMS) and ...
This hiring freeze lead to the USPTO retracting some 600 outstanding job offers to patent examiners earlier this year. Meanwhile, normal attrition in the patent examining corps. has continued.
How in-house patent pros are ‘enablers of innovation’ Iti Negi, a senior patent engineer at Mercedes-Benz, outlines how in-house teams can drive a more effective, inventor-friendly patent process.
GM has filed a patent application for a drone-assisted trailering system that could help users assess vehicle tow readiness and assist in trailering activities.
The MCA has revised equity listing rules via the 2025 amendment. Form LEAP-1 is now mandatory for overseas listings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results